-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Processa Pharmaceuticals, Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q1 2013 to Q3 2022.
- Processa Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2022 was $197K, a 0.73% increase year-over-year.
- Processa Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $788K, a 0.25% decline from 2021.
- Processa Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $790K, a 0.61% decline from 2020.
- Processa Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2020 was $795K, unchanged from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)